StocksAscendis PharmaASND

ASND

Ascendis Pharma

115.01 -1.15 (-0.99%)
Preços adiados pelo NASDAQ, em USD Mercado fechado
Negociar
V
114.74
C
115.35
Top
DeepNews
$ASND (Ascendis Pharma) Ascendis' (ASND) TransCon hGH Gets EU Nod for Pediatric GHD Ascendis Pharma A/S ASND announced that the European Commission has granted marketing authorization to TransCon hGH (Lonapegsomatropin Ascendis Pharma) for the treatment of growth hormone deficiency (“GHD”) in... Mostrar mais Traduzir
DeepNews
$ASND (Ascendis Pharma) Ascendis Pharma's Growth Hormone Deficiency Med Scores European Approval The European Commission (EC) has granted marketing authorization to Ascendis Pharma A/S's (NASDAQ: ASND) Lonapegsomatropin (developed under the name TransCon hGH). The approval for TransCon covers... Mostrar mais Traduzir
DeepNews
$ASND (Ascendis Pharma) Ascendis Pharma A/S Provides Update on Vision 3x3 Strategic Roadmap at 40th Annual J.P. Morgan Healthcare Conference A/S (Nasdaq: ASND) today announced that the Company will today provide an update on its Vision 3x3 and planned 2022 key milestones at the 40th Annual J.P. Morgan... Mostrar mais Traduzir
VolatilityAlerts
$ASND (Ascendis Pharma) rises 6.0% - Will it keep climbing?Traduzir
ASND
Ascendis Pharma
114.74
-1.15 (-0.99%)
VolatilityAlerts
Losing ground: $ASND (Ascendis Pharma) shares slip 5.1%Traduzir
ASND
Ascendis Pharma
114.74
-1.15 (-0.99%)